Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 09/10/2021

Closing price: 299.81

Support price level:	N/A
Resistance price level:	$327.78
Relative strength index (14-day RSI)	16.0
Beta	0.11

BIIB is one of this month's worst performers with a return of -12.0%, underperforming 90 percent of stocks in the S&P-100.
Down 10.7 percent, BIIB is one of this week's biggest decliners.
The price of this low-beta stock is expected to increase by 0.11% for every 1% increase in the S&P-500.
BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 69.9%.
Volatility is forecast to fall over the next month.
With RSI < 30, BIIB is oversold. Odds slightly favor a short-term price reversal.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$236.26	$414.71	42.3%

200 day	50 day	20 day	10 day
$293.95	$337.42	$336.06	$328.27

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
44.6%	37.4%	69.9%	48.9%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: